Otonomy Gets Another Vote of Confidence from SunTrust


Otonomy Inc (NASDAQ:OTIC) magnetized Street-wide attention after Wednesday’s triumphant Phase III home run in Meniere’s, leading investors to send the stock racing up 83% in value. SunTrust analyst Edward Nash sees a meaningful value driver ahead by the first quarter of 2018, bullish on Otividex’s clinical trajectory ahead.

Story Continues